Related Experiment Video
Updated: Apr 15, 2026

Purification of Ubiquitinated p53 Proteins from Mammalian Cells
Published on: March 21, 2022
Regulation of protein quality control by UBE4B and LSD1 through p53-mediated transcription
Goran Periz1, Jiayin Lu1, Tao Zhang1
1Department of Biochemistry and Molecular Biology and Department of Neuroscience, Bloomberg School of Public Health and School of Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America.
Abstract:
Protein quality control is essential for clearing misfolded and aggregated proteins from the cell, and its failure is associated with many neurodegenerative disorders. Here, we identify two genes, ufd-2 and spr-5, that when inactivated, synergistically and robustly suppress neurotoxicity associated with misfolded proteins in Caenorhabditis elegans. Loss of human orthologs ubiquitination factor E4 B (UBE4B) and lysine-specific demethylase 1 (LSD1), respectively encoding a ubiquitin ligase and a lysine-specific demethylase, promotes the clearance of misfolded proteins in mammalian cells by activating both proteasomal and autophagic degradation machineries. An unbiased search in this pathway reveals a downstream effector as the transcription factor p53, a shared substrate of UBE4B and LSD1 that functions as a key regulator of protein quality control to protect against proteotoxicity. These studies identify a new protein quality control pathway via regulation of transcription factors and point to the augmentation of protein quality control as a wide-spectrum antiproteotoxicity strategy.
Insights
Inactivating genes ufd-2 and spr-5 suppresses neurotoxicity from misfolded proteins. Their human counterparts, UBE4B and LSD1, enhance protein clearance, revealing a new quality control pathway involving transcription factor p53.
Area of Science:
- Molecular Biology
- Cell Biology
- Neuroscience
Background:
- Protein quality control (PQC) is vital for cellular health, preventing the accumulation of misfolded and aggregated proteins.
- Dysfunctional PQC is implicated in various neurodegenerative diseases, highlighting the need for therapeutic targets.
- Identifying novel pathways that enhance PQC is crucial for combating proteotoxicity.
Purpose of the Study:
- To identify genetic factors that suppress neurotoxicity caused by misfolded proteins.
- To elucidate the molecular mechanisms underlying protein clearance and PQC.
- To explore the therapeutic potential of augmenting PQC pathways.
Main Methods:
- Utilized Caenorhabditis elegans as a model organism to screen for suppressors of neurotoxicity.
- Investigated the function of mammalian orthologs, UBE4B and LSD1, in protein degradation.
- Employed unbiased screening to identify downstream effectors in the PQC pathway.
Main Results:
- Loss of function in ufd-2 and spr-5 genes synergistically suppressed neurotoxicity in C. elegans.
- Human orthologs UBE4B (ubiquitin ligase) and LSD1 (lysine-specific demethylase) promote clearance of misfolded proteins in mammalian cells.
- Activation of both proteasomal and autophagic degradation pathways was observed.
- Transcription factor p53 was identified as a key downstream effector and shared substrate of UBE4B and LSD1.
Conclusions:
- A novel PQC pathway regulated by UBE4B, LSD1, and p53 has been identified.
- Augmenting this pathway represents a promising, broad-spectrum strategy against proteotoxicity and neurodegeneration.
- Targeting transcription factor regulation offers a new avenue for therapeutic intervention in protein misfolding diseases.
Related Concept Videos
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Regulated Protein Degradation
Abnormal Proliferation
Regulation of Expression at Multiple Steps
Regulation of the Unfolded Protein Response

